aiqbench analysis

INmune Bio and QCi are leveraging the synergy between quantum computing and artificial intelligence to accelerate drug discovery, specifically targeting applications in oncology. This collaboration represents a practical integration of advanced computational methods rather than a standalone announcement of new consumer hardware or general software updates. The core value lies in how these technologies combine to solve complex molecular modeling problems that are currently intractable for classical systems.